AFC-HD AMS Life Science Co., Ltd. - Laporan Laba Rugi (TTM)

AFC-HD AMS Life Science Co., Ltd.
JP ˙ TSE ˙ JP3124700000
JP¥ 866.00 ↑4.00 (0.46%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi AFC-HD AMS Life Science Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
11-30
2021
02-28
2021
05-31
2021
08-31
2021
11-30
2022
02-28
2022
05-31
2022
08-31
2022
11-30
2023
02-28
2023
05-31
2023
08-31
2023
11-30
2024
02-29
2024
08-31
2024
11-30
2025
02-28
2025
05-31
Revenue 16,603 17,077 18,641 22,368 23,185 24,406 24,565 22,997 23,229 24,253 25,000 25,579 26,679 27,677 30,185 31,588 32,257 32,578
Change (%) 2.85 9.16 19.99 3.65 5.27 0.65 -6.38 1.01 4.41 3.08 2.32 4.30 3.74 9.06 4.65 2.12 1.00
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 11,768 12,017 12,812 15,503 15,700 16,115 16,053 14,418 14,486 15,254 15,848 16,256 17,113 17,772 19,694 20,745 21,368 21,459
Change (%) 2.12 6.62 21.00 1.27 2.64 -0.38 -10.19 0.47 5.30 3.89 2.57 5.27 3.85 10.81 5.34 3.00 0.43
% of Revenue 70.88 70.37 68.73 69.31 67.72 66.03 65.35 62.70 62.36 62.90 63.39 63.55 64.14 64.21 65.24 65.67 66.24 65.87
Gross Operating Profit 4,835 5,060 5,829 6,865 7,485 8,291 8,512 8,579 8,743 8,999 9,152 9,323 9,566 9,905 10,491 10,843 10,889 11,119
Change (%) 4.65 15.20 17.77 9.03 10.77 2.67 0.79 1.91 2.93 1.70 1.87 2.61 3.54 5.92 3.36 0.42 2.11
% of Revenue 29.12 29.63 31.27 30.69 32.28 33.97 34.65 37.30 37.64 37.10 36.61 36.45 35.86 35.79 34.76 34.33 33.76 34.13
SG&A 3,443 3,514 3,606 4,580 5,593 6,572 7,461 7,415 7,523 7,607 7,617 7,526 7,512 7,763 8,353 8,534 8,479 8,624
Change (%) 2.06 2.62 27.01 22.12 17.50 13.53 -0.62 1.46 1.12 0.13 -1.19 -0.19 3.34 7.60 2.17 -0.64 1.71
% of Revenue 20.74 20.58 19.34 20.48 24.12 26.93 30.37 32.24 32.39 31.37 30.47 29.42 28.16 28.05 27.67 27.02 26.29 26.47
R&D
Change (%)
% of Revenue
OpEx 15,212 15,532 16,419 20,122 21,332 22,726 23,553 21,985 22,161 23,013 23,617 23,942 24,785 25,695 28,269 29,501 30,069 30,305
Change (%) 2.10 5.71 22.55 6.01 6.53 3.64 -6.66 0.80 3.84 2.62 1.38 3.52 3.67 10.02 4.36 1.93 0.78
% of Revenue 91.62 90.95 88.08 89.96 92.01 93.12 95.88 95.60 95.40 94.89 94.47 93.60 92.90 92.84 93.65 93.39 93.22 93.02
Operating Income 1,391 1,545 2,222 2,246 1,853 1,680 1,012 1,012 1,068 1,240 1,383 1,637 1,894 1,982 1,916 2,087 2,188 2,273
Change (%) 11.07 43.82 1.08 -17.50 -9.34 -39.76 0.00 5.53 16.10 11.53 18.37 15.70 4.65 -3.33 8.92 4.84 3.88
% of Revenue 8.38 9.05 11.92 10.04 7.99 6.88 4.12 4.40 4.60 5.11 5.53 6.40 7.10 7.16 6.35 6.61 6.78 6.98
Interest Expense -31 -31 -30 -50 -59 -65 -71 -57 -55 -54 -55 -57 -60 -69 -101 -121 -147 -175
Change (%) -0.00 -3.23 66.67 18.00 10.17 9.23 -19.72 -3.51 -1.82 1.85 3.64 5.26 15.00 46.38 19.80 21.49 19.05
% of Revenue -0.19 -0.18 -0.16 -0.22 -0.25 -0.27 -0.29 -0.25 -0.24 -0.22 -0.22 -0.22 -0.22 -0.25 -0.33 -0.38 -0.46 -0.54
Net Income 890 1,058 1,594 1,495 1,276 1,068 671 735 739 842 882 1,102 1,260 1,329 1,252 1,394 1,492 1,742
Change (%) 18.88 50.66 -6.21 -14.65 -16.30 -37.17 9.54 0.54 13.94 4.75 24.94 14.34 5.48 -5.79 11.34 7.03 16.76
% of Revenue 5.36 6.20 8.55 6.68 5.50 4.38 2.73 3.20 3.18 3.47 3.53 4.31 4.72 4.80 4.15 4.41 4.63 5.35

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista